- Landmark Lawsuit Claims Monsanto Hid Cancer Danger of Weedkiller for Decades, by Carey Gillam in The Guardian
- First Monsanto Roundup Cancer Trial Jury Selection, Carey Gillam’s blog
By Carey Gillam
Let the battle begin. Opening statements are slated for Monday in the landmark legal case that for the first time puts Monsanto and its Roundup herbicide on trial over allegations that the company’s widely used weed killer can cause cancer.
Dewayne “Lee” Johnson, a San Francisco-area school groundskeeper who used a form of Roundup regularly at his job, will face off against the global seed and chemical giant in a trial expected to extend into August. Johnson hopes to persuade a jury that Monsanto, which last month became a subsidiary of Bayer AG, is to blame for the non-Hodgkin lymphoma that doctors have said leaves him only weeks or months left to live.
Hints of the courtroom drama to come unfolded over the last week of June as jury selection dragged on for days, with Monsanto claiming widespread bias among prospective jurors. A number of the members of the jury pool, Monsanto’s attorney said, revealed in jury questionnaires that they view Monsanto as “evil.” Some even said they believe the company has “killed people,” a Monsanto attorney lawyer told San Francisco Superior Court Judge Suzanne Bolanos.
Monsanto’s attorneys cited similar issues in seeking to quell media coverage of the trial, telling the judge that she should not allow news cameras to televise the events because the publicity would “create a significant safety risk” for Monsanto’s employees and attorneys who have been targeted with “multiple threats and disturbing communications,” related to the litigation. Monsanto said employees have received threatening phone calls as well as ominous postcards sent to their homes. One postcard displayed a skull and crossbones along with a photo of the recipient, Monsanto said in a court filing.
Judge Bolanos ruled that some parts of the trial will be allowed to be broadcast, including opening statements, closing arguments and the announcement of a verdict. The trial is expected to be closely followed by people around the world; the French news outlet Agence France Presse is among the contingent of media who sought permission to cover the case.
Heated debates over the safety of Roundup and the active ingredient glyphosate have spanned the globe for years. Concerns mounted after internal Monsanto documents came to light through court-ordered discovery, showing conversations among Monsanto employees about “ghost” writing certain scientific papers to help influence regulatory and public opinion about Monsanto products.
Many of those internal corporate records are expected to be a key part of Johnson’s case. Johnson’s attorneys say they have evidence that Monsanto has long known that glyphosate-based herbicides such as Roundup are carcinogenic and have hidden that information from consumers and regulators. They allege Monsanto has manipulated the scientific record and regulatory assessments of glyphosate in order to protect corporate glyphosate-related revenues. Monsanto knew of the dangers and “made conscious decisions not to redesign, warn or inform the unsuspecting public,” the Johnson lawsuit claims.
If they can convince a jury of the allegations, the lawyers say they plan to ask for potentially “hundreds of millions of dollars.”
Johnson’s lawsuit against Monsanto makes him one of roughly 4,000 plaintiffs who sued the company after the International Agency for Research on Cancer (IARC) classified glyphosate as a probable human carcinogen in March 2015. The IARC classification was based on a review of more than a decade of published, peer-reviewed scientific studies analyzing glyphosate and glyphosate-based herbicides. Johnson’s case is the first to go to trial. Another is scheduled for trial in October in St. Louis, Missouri.
Monsanto argues there is no justification for any of the claims, and asserts it has decades of regulatory findings of safety and hundreds of research studies to back its defense. “Glyphosate is the most tested herbicide in history,” Monsanto stated in its trial brief.
The company says it plans to introduce expert testimony demonstrating that the science is firmly on its side—”the entire body of epidemiology literature shows no causal association” between its glyphosate-based herbicides and non-Hodgkin lymphoma, the company states. As well, the animal testing database “is most consistent with glyphosate not being a human carcinogen,” according to Monsanto.
The company’s attorneys also plan to show that Johnson’s exposure was minimal, and notably, that development of his type of cancer—a disease called mycosis fungoides that causes lesions on the skin—takes many years to form and could not have developed in the short period between Johnson’s exposure and his diagnosis.
Monsanto’s attorneys argue in court filings that Johnson’s claims are so weak the judge should instruct the jury to provide a directed verdict in Monsanto’s favor.
But Johnson’s attorneys plan to tell jury members that Johnson began to experience a skin rash not long after being accidentally doused in a Monsanto glyphosate-based herbicide called Ranger Pro. He saw the rash—which turned to lesions and then invaded lymph nodes—worsen after he would use the chemical, which was frequently as he treated school grounds. Johnson’s attorneys plan to tell jurors that Johnson was so worried that the herbicide was to blame that he called Monsanto’s offices as well as a poison hotline number listed on the herbicide label. Monsanto employees recorded his outreach and his concerns, internal Monsanto documents show. But even after the IARC classification of glyphosate as a probable carcinogen, Monsanto did not inform him of any risk, according to evidence to be presented at the trial.
As part of their case, Johnson’s attorneys intend to present video depositions of 10 former or current Monsanto employees, and of former Environmental Protection Agency official Jess Rowland, whose relationship with Monsanto has sparked allegations of collusion and an inquiry from the EPA’s Office of Inspector General. They also will call to the stand Johnson himself, his wife, his doctors, and several scientists as expert witnesses.
The Monsanto witness list includes 11 expert witnesses who will testify both about the necessity of herbicides, including glyphosate-based herbicides; certain scientific literature; the plaintiff’s type of cancer and potential causes; and other evidence that Monsanto says discredits Johnson’s claims.
Johnson’s attorneys will start the opening statements on Monday, and have projected that initial explanation of their case to the jury will take roughly 1-1/2 hours. Monsanto’s attorneys have told the court they expect their opening statements to take roughly 1-1/4 hours.
This story originally appeared in EcoWatch.
Academics Review, a nonprofit 501(c)(3) organization launched in 2012, claims to be an independent group but documents obtained by U.S. Right to Know revealed it is a front group set up with the help of Monsanto and its public relations team to attack agrichemical industry critics while appearing to be independent.
Related: Genetic Literacy Project, Monsanto partner groups, Biotech Literacy Project boot camps
“Monsanto Fingerprints Found All Over Attack on Organic Food,” by Stacy Malkan, Huffington Post (2016)
Covert industry funding
The Academics Review website describes its founders as “two independent professors,” Bruce Chassy, PhD, professor emeritus at the University of Illinois at Urbana-Champaign, and David Tribe, PhD, senior lecturer at the University of Melbourne, Australia. As of May 2018, the website claims, “Academics Review only accepts unrestricted donations from non-corporate sources to support our work.”
However, tax records show that the primary funder of Academics Review has been the Council for Biotechnology Information, a trade association that is funded and run by the largest agrichemical companies: BASF, Bayer, DowDuPont, Monsanto and Syngenta.
According to CBI tax records, the industry-funded group gave Academics Review a total of $650,000 in 2014 and 2015-2016. Tax records for AcademicsReview.org report expenses of $791,064 from 2013-2016 (see 2013, 2014, 2015, 2016). The money was spent on organizing conferences and promoting GMOs and pesticides, according to the tax records.
Emails reveal secret origin of academic front group
Emails obtained by U.S. Right to Know via state Freedom of Information requests revealed the inner workings of how Academics Review was set up as a front group with the help of Monsanto, its PR allies and industry funders. Key facts and emails:
- Eric Sachs, a senior public relations executive at Monsanto, said he would help find industry funding for Academics Review. “The key will be keeping Monsanto in the background so as not to harm the credibility of the information,” Sachs wrote to Chassy on November 30, 2010.
- Academics Review was conceived as a front group that could attack critics of the agrichemical industry. According to a March 11, 2010 email chain, the group was established with the help of Monsanto executives along with Jay Byrne, former director of corporate communications at Monsanto who now runs a PR shop called v-Fluence Interactive; and Val Giddings, former VP of the biotech industry trade association BIO.
- Byrne compared the concept as similar to – but better than – a front group set up by Rick Berman, a lobbyist known as “Dr. Evil” and the “king of corporate front groups and propaganda” for his work to promote tobacco and oil industry interests under the cover of neutral-sounding groups. Berman’s “’Center for Consumer Freedom’ (ActivistCash.com) has cashed in on this to the extreme; and I think we have a much better concept,” Byrne wrote to Chassy on March 11, 2010.
- Byrne said he was developing an “opportunities list with targets” for Monsanto comprised of “individuals organizations, content items and topic areas” critical of ag-biotech that “mean money for a range of well heeled corporations.”
- Chassy indicated he was especially keen to go after the organic industry. “I would love to find a prime name in the middle of the organic aura from which to launch ballistic missiles,” he wrote on March 11, 2010. In 2014, Academics Review attacked the organic industry with a report it falsely claimed was the work of independent academics with no conflicts of interest.
Monsanto plan names Academics Review as “industry partner”
Academics Review is an “industry partner”according to a confidential Monsanto PR document that describes the corporation’s plans to discredit the World Health Organization’s cancer research arm, the International Agency for Research on Cancer (IARC), in order to defend the reputation of Roundup weedkiller. On March 20, 2015, IARC announced it had classified glyphosate as Group 2A carcinogen, “probably carcinogenic to humans.”
The Monsanto PR document lists four tiers of industry partners to engage in its public relations efforts to discredit the cancer panel’s report. Academics Review was listed as a Tier 2 “industry partner” along with Genetic Literacy Project, Sense About Science, Biofortified, and the AgBioChatter academics list serve.
An Academics Review article dated March 25, 2015 claimed the “IARC glyphosate cancer review fails on multiple fronts.” The article linked to the industry-funded GMO Answers, the front group American Council on Science and Health and a Forbes article by Henry Miller that was ghostwritten by Monsanto.
Bruce Chassy’s ties to industry and its front groups
Professor Bruce Chassy, co-founder of Academics Review and president of the board, has been frequently cited in the media as an independent expert on GMOs, while he was also receiving undisclosed funds from Monsanto.
Chassy had received $57,000 in undisclosed funds over a two-year period from Monsanto to travel, write and speak about GMOs, according to WBEZ. The story reported that Monsanto also sent at least $5.1 million through the University of Illinois Foundation to university employees and programs between 2005 and 2015.
Chassy is on the “Board of Science and Policy Advisors” of the American Council on Science and Health, an industry funded front group that works with Monsanto. Chassy is also an “independent expert” for GMO Answers, a marketing website for GMOs and pesticides funded by the agrichemical industry.
Articles about Bruce Chassy’s industry ties:
- New York Times, “Food Industry Enlisted Academics in G.M.O. Lobbying War, Emails Show,” by Eric Lipton (9/5/2015)
- New York Times email archive, “A University of Illinois Professor Joins the Fight,” (9/5/2015)
- WBEZ, “Why Didn’t an Illinois Professor Have to Disclose GMO Funding,” by Monica Eng (3/15/2016)
- US Right to Know, “Following an Email Trail: How a Public University Professor Collaborated on a Corporate PR Campaign,” by Carey Gillam (1/29/2016)
David Tribe / Academics Review / Biofortified
David Tribe is co-founder of Academics Review, vice president of the Academics Review Board of Directors, and a reviewer on the 2014 Academics Review report attacking the organic industry. Tribe is also a member of the board of directors of Biology Fortified Inc., or Biofortified, a nonprofit group that aids the agrichemical industry with lobbying and public relations.
Industry-funded Biotech Literacy Project Boot Camps: training scientists and journalists to promote GMOs
The Biotech Literacy Project boot camps were a series of conferences funded by the agrichemical industry and organized by Academics Review and Genetic Literacy Project, another group that partners with Monsanto on public relations projects. The boot camps trained scientists and journalists how to present GMOs and pesticides in a more positive light, and had explicit political aims to stave off GMO labeling and prop up flagging support for agrichemical industry products.
Boot camp organizers made false claims to journalists and scientists about the source of funds for the Biotech Literacy Project boot camps; they claimed funding came from a mix of government, academic and industry sources, but the only traceable funders were the agrichemical corporations.
“I was offered a $2,000 honorarium, as well as expenses. I wrote back and asked who would provide the honorarium and was told it’d be a combination of funds from UC Davis, USDA, state money, and the Biotechnology Industry Organization (BIO).” (Journalist Brooke Borel, Popular Science)
“I need to be clear up front that our support comes from BIO, USDA, state-USAID and some foundation money so industry is indirectly a sponsor. We are 100% transparent about sponsorship.” (boot camp organizer Bruce Chassy email to scientists)
The USDA and other government and academic sources named by organizers denied funding the events, according Paul Thacker’s reporting in The Progressive, and the only traceable source of funds was the BIO trade group offshoot, the Council for Biotechnology Information, which is funded by BASF, Bayer, DowDuPont and Monsanto Company. That group spent over $300,000 on the two boot camps held at UC Davis and University of Florida, according to tax records and Thacker’s reporting.
Speakers at the 2015 Biotech Literacy Project boot camp (according to the wrap-up report) included industry executives and public relations operatives, including Monsanto’s former head of communications Jay Byrne (who helped set up Academics Review as a front group to attack industry critics), Hank Campbell of the front group American Council on Science and Health, and Yvette d’Entremont the “SciBabe.”
- The Progressive, “Flacking for GMOs: How the Biotech Industry Cultivates Positive Media – and Discourages Criticism,” by Paul Thacker (7/21/2017)
- Biotech Literacy Project boot camps agenda and participants: University of Florida (2014)and University of California, Davis (2015)
For more information about the findings of U.S. Right to Know and media coverage about collaborations between industry groups and academics on food issues, see our investigations page. U.S. Right to Know documents are also available in the Chemical Industry Documents Library hosted by the University of California, San Francisco.
This article was published the Guardian on April 30, 2018
By Carey Gillam
US government scientists have detected a weedkiller linked to cancer in an array of commonly consumed foods, emails obtained through a freedom of information request show.
The Food and Drug Administration (FDA) has been testing food samples for residues of glyphosate, the active ingredient in hundreds of widely used herbicide products, for two years, but has not yet released any official results.
But the internal documents obtained by the Guardian show the FDA has had trouble finding any food that does not carry traces of the pesticide.
“I have brought wheat crackers, granola cereal and corn meal from home and there’s a fair amount in all of them,” FDA chemist Richard Thompson wrote to colleagues in an email last year regarding glyphosate. Thompson, who is based in an FDA regional laboratory in Arkansas, wrote that broccoli was the only food he had “on hand” that he found to be glyphosate-free.
That internal FDA email, dated January 2017, is part of a string of FDA communications that detail agency efforts to ascertain how much of the popular weedkiller is showing up in American food. The tests mark the agency’s first-ever such examination…
As researchers we often look to documents to shed new light on issues important to food policy. Sometimes, they simply reflect what we already know.
That’s the case with one new communication string that adds to evidence of a far-reaching strategy by food industry players to discredit and diminish the world’s leading cancer research agency. We’ve already seen documents from Monsanto and other chemical industry interests laying out plans to tear apart the credibility of the International Agency for Research on Cancer (IARC) because of its classification of Monsanto’s weed killer glyphosate as a probable human carcinogen.
Now we see evidence that other food industry players are part of the scheme; working to head off potentially damaging IARC scrutiny of food additives such as aspartame, sucralose, and more.
The email of intrigue was obtained through a state open records request. It shows communication between James Coughlin, a one-time scientist for Kraft General Foods Inc. who operates a food and “nutritional” consulting business, and Timothy Pastoor, a retired toxicologist with the agrochemical giant Syngenta AG who now runs his own “science communications” business. Also included on a portion of the email string is Monsanto PR man Jay Byrne, who runs a “reputation management” and public relations business, and Douglas Wolf, a former Environmental Protection Agency scientist now with Syngenta.
In the October 2016 email, Coughlin tells Pastoor how he’s been “fighting IARC forever!!” dating back to his time at Kraft. He relates the time he spent criticizing the international cancer agency to a U.S. House of Representatives staffer who was coordinating an effort to strip U.S. funding from IARC.
And then, articulating the deep fear the food industry holds for the cancer agency, he gets to the meat of the matter: “IARC is killing us!” he writes. The 2-page string can be found here. An excerpt is below:
Whitewash: The Story of a Weed Killer, Cancer and the Corruption of Science, by Carey Gillam (Island Press) has been named an Outstanding Book of the Year by the Independent Book Publisher Awards.
“Hard-hitting, eye-opening narrative…A forceful argument for an agricultural regulatory environment that puts public interest above corporate profits.” Kirkus Reviews
“This is a must-read for everyone concerned about the increasing burden of toxic chemicals in water and food, the health and environmental consequences thereof, and corporate influence on government agencies.” Booklist
“Gillam expertly covers a contentious front where corporate malfeasance intersects with issues of public health and ecology.” Publishers Weekly
“a gutsy, compelling read from beginning to end, especially for readers who enjoy the kind of hard-nosed, shoe-leather reporting that used to be the hallmark of great journalism.” Society for Environmental Journalists BookShelf
“well-documented compendium of wrongs, fraud, conflicts of interest, undue influence, and troubling forms of plain old [PR]….Some of its revelations are downright infuriating.“ Los Angeles Review of Books
See also: Carey Gillam’s testimony before a joint committee of the European Parliament on 10/11/2017 and her reporting from the Daubert Hearings in the Cancer Victims Vs. Monsanto glyphosate litigation.
It’s the pesticide on our dinner plates, a chemical so pervasive it’s in the air we breathe, our water, our soil, and even found increasingly in our own bodies. Known as Monsanto’s Roundup by consumers, and as glyphosate by scientists, the world’s most popular weed killer is used everywhere from backyard gardens to golf courses to millions of acres of farmland. For decades it’s been touted as safe enough to drink, but a growing body of evidence indicates just the opposite, with research tying the chemical to cancers and a host of other health threats.
In Whitewash, veteran journalist Carey Gillam uncovers one of the most controversial stories in the history of food and agriculture, exposing new evidence of corporate influence. Gillam introduces readers to farm families devastated by cancers which they believe are caused by the chemical, and to scientists whose reputations have been smeared for publishing research that contradicted business interests. Readers learn about the arm-twisting of regulators who signed off on the chemical, echoing company assurances of safety even as they permitted higher residues of the pesticide in food and skipped compliance tests. And, in startling detail, Gillam reveals secret industry communications that pull back the curtain on corporate efforts to manipulate public perception.
Whitewash is more than an exposé about the hazards of one chemical or even the influence of one company. It’s a story of power, politics, and the deadly consequences of putting corporate interests ahead of public safety.
Publication date October 2017
More Praise for Whitewash
“The book unravels a tapestry of pesticide industry tricks to manipulate the scientific truths about their products while placing profits above human health and the environment. As someone who has experienced similar actions by corporations firsthand in my work far too often, I am hopeful that Carey’s book will be a wake-up call for more transparency about the dangers surrounding many chemicals in the marketplace.” Erin Brockovich, environmental activist and author
Carey Gillam has brilliantly assembled the facts and describes how Monsanto and other agricultural chemical companies lied about their products, covered up the damaging data and corrupted government officials in order to sell their toxic products around the world. David Schubert, Ph.D., Professor and Head of the Cellular Neurobiology Laboratory at the Salk Institute For Biological Studies
Carey Gillam is a brave warrior in the mold of Rachel Carson. She has exposed the ruthless greed and fraud which have led to the poisoning of our planet. Brian G.M. Durie, M.D. Chairman of the International Myeloma Foundation, oncology specialist and attending physician at Cedars-Sinai Medical Center
In the grand tradition of Silent Spring, Carey Gillam’s Whitewash is a powerful exposé that sheds light on a chemical that — to most of us — is both entirely invisible and yet profoundly damaging to our bodies and our environment. It is a deeply researched, entirely convincing exposé of the politics, economics and global health consequences implicit in the spread of the world’s most common herbicide. Gillam has done what all great journalists strive to do: she has made us see clearly what has long been right before our eyes. Highly recommended. McKay Jenkins, author, Professor of English, Journalism and Environmental Humanities at the University of Delaware
“Science Week” in a federal court will decide if farmer cancer lawsuits move forward
For Immediate Release: Monday, March 5, 2018
For More Information Contact: Carey Gillam (913) 526-6190; Stacy Malkan (510) 542-9224
San Francisco, Calif.; March 5, 2018 — A federal court hearing in San Francisco this week will turn a spotlight on the science surrounding the world’s most widely used pesticide, glyphosate, and will determine whether farmers and their families will be able to proceed with legal action against Monsanto Co. over cancer concerns.
More than 365 lawsuits are pending against Monsanto in U.S. District Court in San Francisco, filed by people alleging that exposure to Roundup herbicide caused them or their loved ones to develop non-Hodgkin lymphoma, and that Monsanto covered up the risks.
The court has dubbed the March 5-9 events as “science week” because the only evidence to be presented will come from experts in cancer science, including epidemiologists, toxicologists, and biomedical statistical analysts called to analyze relevant research. The scientists will present their best scientific evidence to U.S. Judge Vince Chhabria, who will decide if the lawsuits move forward or are halted in their tracks.
Journalist and author Carey Gillam of U.S. Right to Know will be live blogging the event from the court house. Follow her posts here: https://usrtk.org/live-updates-monsanto-hearing/
See also: “Monsanto says its pesticides are safe: Now a court wants to see the proof,” by Carey Gillam, The Guardian.
Gillam is author of “Whitewash: The Story of a Weed Killer, Cancer and the Corruption of Science” (Island Press, 2017) — “a gutsy, compelling read from beginning to end, especially for readers who enjoy the kind of hard-nosed, shoe-leather reporting that used to be the hallmark of great journalism,” according to the Society for Environmental Journalists’ BookShelf review.
Gillam is also research director of U.S. Right to Know, a consumer and public health watchdog group. USRTK is posting documents and analysis from the MDL glyphosate cancer cases on our Monsanto Papers page.
U.S. Right to Know is a nonprofit consumer and public health organization that investigates the risks associated with the corporate food system, and the food industry’s practices and influence on public policy. For more information, see usrtk.org.
Score another point for corporate power over protection of the public.
Given the fact that cancer is the second-leading cause of death in the United States, it seems obvious that our lawmakers should be supporting cancer science rather than trying to thwart it. But Smith’s action comes after the World Health Organization’s International Agency for Research on Cancer ( IARC) angered Monsanto Co. when it declared the pesticide glyphosate, a key ingredient in Monsanto’s weed killing products, to be a probable carcinogen.
Though the hearing is titled “In Defense of Scientific Integrity: Examining the IARC Monograph Programme and Glyphosate Review,” the irony of the descriptor is not lost on those who have been following Smith’s efforts to derail and defund this cancer research agency.
In letters to IARC’s leadership, Smith has repeated false narratives and inaccurate news stories planted by Monsanto and chemical industry allies, and cited the “serious nature of these concerns related to expenditures of taxpayer dollars.”
It’s worth noting that the plan to put the International Agency for Research on Cancer on the hot seat was put into motion roughly three years ago when Monsanto predicted the international cancer scientists would find its weed killer to have carcinogenic potential. The company said as much in internal communications brought to light through recent litigation.
The documents also show that it was February 2015, a month before the IARC classification, when Monsanto executives laid out a strategic plan to discredit the cancer scientists. The plan was designed to “orchestrate outcry with IARC decision.”
The efforts to manipulate public perception about IARC ramped up last summer when Monsanto allies spoon-fed a false narrative to a Reuters reporter who produced a news story that shot around the globe and has been a key talking point for the chemical industry attack against IARC.
The story relied on the deposition of an IARC scientist named Aaron Blair and reported that Blair withheld critical information that would have altered the IARC glyphosate classification. Reuters never provided a link to the deposition, which at that point was not filed in any court and was not publicly available.
Chairman Smith ran with the story, stating that Blair “admitted to knowing that this research could have prevented” the classification of glyphosate as a probable carcinogen.
Anyone taking time to actually read the deposition, which is now public, would see that Blair never said any such thing, and in fact protested multiple times that the data in question was not fully analyzed and not published and thus was not suitable to be considered by IARC.
A similar false narrative pushed by the chemical industry and repeated by Smith accused IARC of deleting assessments finding no connection between glyphosate and cancer from its final report. Smith and team either don’t know or don’t care that IARC’s deletions were of Monsanto assertions that the cancer scientists said could not be substantiated.
IARC officials have detailed the falsehoods perpetuated against them by the chemical industry but the defense has fallen on deaf ears.
Monsanto needs to discredit the international cancer scientists because it was the IARC finding that triggered waves of lawsuits against Monsanto, and prompted moves to ban the chemical in some European countries.
But while Monsanto and other chemical industry interests are concerned about the billions of dollars in revenues they rake in annually from glyphosate-based products, the attack on this independent science group should have all of us concerned.
Approximately 39 percent of men and women living in the United States are expected to be diagnosed with cancer during their lifetimes, according to the National Cancer Institute.
For this year alone, the American Cancer Society has estimated there will be more than 1.68 million people newly diagnosed with cancer and more than 600,000 deaths from cancer. Worldwide, there are more that 14 million cases of cancer occurring each year, and that number is expected to hit nearly 22 million by 2030.
Cancer “affects almost everyone’s life, either directly or indirectly,” and beyond the toll on life and health it costs the United States more than $200 billion in medical costs and lost productivity, according to the U.S. Department of Health and Human Services (HHS).
In order to reduce deaths from cancer we have to put more emphasis on preventing it in the first place, and a big part of that “primary prevention” according to a 2016 report by the HHS National Toxicology Program (NTP) “is to identify the carcinogens.”
Clearly, the companies that sell chemicals linked to cancer prefer to see IARC defunded and dismantled. They’ve said as much through the disingenuously named Council for Accuracy in Public Health Research (CAPHR), a nonprofit established by the American Chemistry Council a year ago with the specific goal of promoting the “reform” of IARC.
But to see our lawmakers so eagerly promoting corporate interests when such dire public safety interests are at stake marks perhaps a new low in American politics. These are literally life and death matters.
Our public servants must be held to account, to support the scientists who work to identify carcinogens, and push back against the corporate interests who want to discredit the science that threatens its profits.
Scientific integrity should mean exactly that.
By Carey Gillam
My friend died from cancer today.
His was a short, eight-month-long battle for survival, but it was a brutal one. Now his wife and young children are not planning for Christmas; instead they are planning his funeral.
This man’s passing is a tragedy for his family and friends to be sure. But it also serves as a sad reminder of the tight grip cancer has taken on so many lives.
Approximately 39 percent of men and women living in the United States are expected to be diagnosed with cancer at some point during their lifetimes, according to the National Cancer Institute. For this year alone, the American Cancer Society has estimated there will be more than 1.68 million people newly diagnosed with cancer and more than 600,000 deaths from cancer. Cancer is the second-leading cause of death in the United States.
One of the sinister twists to this creeping killer is that while we know the myriad types of cancers are caused by mutations to the DNA within cells, pinpointing exactly what agent or actions triggered the deadly DNA changes that led to a specific cancer in a specific individual is not easy.
Researchers say there are an array of causes for cancer, including an unhealthy diet, obesity and alcohol intake. Researchers also point to what they call “environmental pollutants” ― substances such asbestos, arsenic, benzene, chromium and, notably, the pesticides that have become pervasive in our lives in recent decades and are used by farmers in food production.
Data from our Food and Drug Administration (FDA) and U.S. Department of Agriculture (USDA) show that foods we eat on a regular basis contain residues of hundreds of different pesticides, tiny invisible traces of insecticides and weed killers in thousands of commonly consumed foods, including fruits and vegetables. We are also exposed to pesticides in our drinking water, and through applications made to our parks and playgrounds, lawns and gardens and schoolyards. Pesticides are also often sprayed from the air across fields and forestry.
Research suggests a possible connection between pesticides and cancers such as non-Hodgkin lymphoma, multiple myeloma, and prostate, liver, pancreatic, lung and non-melanoma skin cancers. The American Academy of Pediatrics is so concerned that it is on record voicing its concerns about pesticides and ties to childhood cancers, and has called for greater protections from exposures.
The Pesticide Action Network North America, a consumer and environmental advocacy group, says that evidence is growing ever stronger that pesticide exposure is a key contributor to what the organization calls a “cancer epidemic.”
Worldwide, there are more that 14 million cases of cancer occurring each year, and that number is expected to hit nearly 22 million by 2030. Cancer “affects almost everyone’s life, either directly or indirectly,” and beyond the toll on life and health it costs the United States more than $200 billion in medical costs and lost productivity, according to the U.S. Department of Health and Human Services (HHS).
In order to reduce deaths from cancer we have to put more emphasis on preventing it in the first place, and a big part of that “primary prevention” has to do with addressing environmental causes, according to a 2016 report by the HHS National Toxicology Program (NTP). “An important step in primary prevention,” the NTP states, “is to identify the carcinogens.”
It is not a good sign that some members of Congress are now working to discredit and defund the International Agency for Research on Cancer (IARC), an arm of the World Health Organization specifically charged with identifying and classifying potential carcinogens. The actions by Republicans within the U.S. House of Representatives Committee on Science, Space, and Technology come after IARC angered Monsanto Co. when it declared the pesticide glyphosate, a key ingredient in Monsanto’s weed killing products, a probable carcinogen.
It is also not encouraging that President Trump nominated a pesticide safety advocate to oversee the Environmental Protection Agency’s chemical safety division. The nominee, Michael Dourson, has spent many years helping companies fight restrictions on potentially toxic chemicals. It is heartening, however, that strong opposition and outrage over Dourson’s nomination forced him to withdraw from consideration for the post on Wednesday.
Certainly, we all know someone with cancer or someone who has had it. But we cannot afford to become complacent, to accept this as normal, to allow politics to take precedence over public health. We need to work harder to support the science that identifies carcinogens, to encourage and fund research into alternatives to a toxic landscape, and to hold our regulators and lawmakers accountable for enforcing protective measures that limit our exposures to environmental pollutants.
I lost a friend to cancer today. It was just before dawn when he slipped away. A wife lost her husband of 30 years, a son and a daughter lost a father, and countless neighbors and friends lost a kind and generous soul, a man who devoted endless hours to coaching, mentoring and encouraging a community’s children alongside his own.
The losses are too great.
This article first appeared in the Huffington Post.